These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30135178)

  • 1. Organic Anion Transporter 2-Mediated Hepatic Uptake Contributes to the Clearance of High-Permeability-Low-Molecular-Weight Acid and Zwitterion Drugs: Evaluation Using 25 Drugs.
    Kimoto E; Mathialagan S; Tylaska L; Niosi M; Lin J; Carlo AA; Tess DA; Varma MVS
    J Pharmacol Exp Ther; 2018 Nov; 367(2):322-334. PubMed ID: 30135178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organic Anion Transporter 2 Mediates Hepatic Uptake of Tolbutamide, a CYP2C9 Probe Drug.
    Bi YA; Mathialagan S; Tylaska L; Fu M; Keefer J; Vildhede A; Costales C; Rodrigues AD; Varma MVS
    J Pharmacol Exp Ther; 2018 Mar; 364(3):390-398. PubMed ID: 29326367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: "SLC-Phenotyping" Using Primary Human Hepatocytes.
    Bi YA; Costales C; Mathialagan S; West M; Eatemadpour S; Lazzaro S; Tylaska L; Scialis R; Zhang H; Umland J; Kimoto E; Tess DA; Feng B; Tremaine LM; Varma MVS; Rodrigues AD
    J Pharmacol Exp Ther; 2019 Jul; 370(1):72-83. PubMed ID: 30975793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Hepatic Organic Anion Transporter 2 in the Pharmacokinetics of R- and S-Warfarin: In Vitro Studies and Mechanistic Evaluation.
    Bi YA; Lin J; Mathialagan S; Tylaska L; Callegari E; Rodrigues AD; Varma MVS
    Mol Pharm; 2018 Mar; 15(3):1284-1295. PubMed ID: 29433307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic acid transport into human liver involves organic anion transporter 2 (SLC22A7).
    Mathialagan S; Bi YA; Costales C; Kalgutkar AS; Rodrigues AD; Varma MVS
    Biochem Pharmacol; 2020 Apr; 174():113829. PubMed ID: 32001236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
    Kunze A; Huwyler J; Camenisch G; Poller B
    Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary Hepatocytes.
    Vildhede A; Kimoto E; Rodrigues AD; Varma MVS
    Mol Pharm; 2018 Aug; 15(8):3227-3235. PubMed ID: 29906129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far?
    Alluri RV; Li R; Varma MVS
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):387-401. PubMed ID: 32228316
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).
    Varma MV; Steyn SJ; Allerton C; El-Kattan AF
    Pharm Res; 2015 Dec; 32(12):3785-802. PubMed ID: 26155985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Human Plasma on Hepatic Uptake of Organic Anion-Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes.
    Bi YA; Ryu S; Tess DA; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2021 Jan; 49(1):72-83. PubMed ID: 33139461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies to improve the prediction accuracy of hepatic intrinsic clearance of three antidiabetic drugs: Application of the extended clearance concept and consideration of the effect of albumin on CYP2C metabolism and OATP1B-mediated hepatic uptake.
    Fujino R; Hashizume K; Aoyama S; Maeda K; Ito K; Toshimoto K; Lee W; Ninomiya SI; Sugiyama Y
    Eur J Pharm Sci; 2018 Dec; 125():181-192. PubMed ID: 30287410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro-In Vivo Extrapolation Approaches.
    Izumi S; Nozaki Y; Komori T; Takenaka O; Maeda K; Kusuhara H; Sugiyama Y
    J Pharm Sci; 2017 Sep; 106(9):2678-2687. PubMed ID: 28238896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro-In Vivo Scaling of Hepatic Uptake Clearance.
    De Bruyn T; Ufuk A; Cantrill C; Kosa RE; Bi YA; Niosi M; Modi S; Rodrigues AD; Tremaine LM; Varma MVS; Galetin A; Houston JB
    Drug Metab Dispos; 2018 Jul; 46(7):989-1000. PubMed ID: 29720472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
    Bachmakov I; Glaeser H; Fromm MF; König J
    Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling.
    Mitra P; Weinheimer S; Michalewicz M; Taub ME
    Drug Metab Dispos; 2018 Jul; 46(7):953-963. PubMed ID: 29666154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
    Noé J; Portmann R; Brun ME; Funk C
    Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
    Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
    Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling.
    Bosgra S; van de Steeg E; Vlaming ML; Verhoeckx KC; Huisman MT; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Dec; 65():156-66. PubMed ID: 25261337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.